Literature DB >> 1315045

Mutations in the bovine leukemia virus Tax protein can abrogate the long terminal repeat-directed transactivating activity without concomitant loss of transforming potential.

L Willems1, C Grimonpont, H Heremans, N Rebeyrotte, G Chen, D Portetelle, A Burny, R Kettmann.   

Abstract

The bovine leukemia virus Tax protein transactivates gene expression directed by the viral long terminal repeat (LTR) and contributes to immortalization of primary cells. Theoretical analysis of the protein sequence revealed the presence of a putative zinc finger structure at its amino end. Selected mutations in that region completely abolished transactivation, demonstrating its importance for LTR-directed gene regulation. However, these mutations did not interfere with the ability of tax to bind zinc or to contribute to immortalization of primary cells. Thus, transactivation of bovine leukemia virus LTR and target cell transformation are independent functions of Tax and involve different functional domains of the protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315045      PMCID: PMC525610          DOI: 10.1073/pnas.89.9.3957

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.

Authors:  J A DeCaprio; J W Ludlow; J Figge; J Y Shew; C M Huang; W H Lee; E Marsilio; E Paucha; D M Livingston
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

4.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

5.  Transdominant human T-cell lymphotropic virus type I TAX1 mutant that fails to localize to the nucleus.

Authors:  S D Gitlin; P F Lindholm; S J Marriott; J N Brady
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes.

Authors:  M R Smith; W C Greene
Journal:  Genes Dev       Date:  1990-11       Impact factor: 11.361

7.  Structural and functional characterization of mutants of the bovine leukemia virus transactivator protein p34.

Authors:  L Willems; G Chen; D Portetelle; R Mamoun; A Burny; R Kettmann
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

8.  The nucleotide sequence of the env gene and post-env region of bovine leukemia virus.

Authors:  N R Rice; R M Stephens; D Couez; J Deschamps; R Kettmann; A Burny; R V Gilden
Journal:  Virology       Date:  1984-10-15       Impact factor: 3.616

9.  Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1.

Authors:  J Inoue; M Seiki; T Taniguchi; S Tsuru; M Yoshida
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

10.  The bovine leukemia virus p34 is a transactivator protein.

Authors:  L Willems; A Gegonne; G Chen; A Burny; R Kettmann; J Ghysdael
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  19 in total

1.  Assessment of bovine leukemia virus transcripts in vivo.

Authors:  J Rovnak; J W Casey
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Discordance between bovine leukemia virus tax immortalization in vitro and oncogenicity in vivo.

Authors:  J C Twizere; P Kerkhofs; A Burny; D Portetelle; R Kettmann; L Willems
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Tax & rex: overlapping genes of the Deltaretrovirus group.

Authors:  Kathleen Margaret McGirr; Gertrude Case Buehuring
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

4.  CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis.

Authors:  G H Cantor; S M Pritchard; F Dequiedt; L Willems; R Kettmann; W C Davis
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Role of the proline-rich motif of bovine leukemia virus transmembrane protein gp30 in viral load and pathogenicity in sheep.

Authors:  M Reichert; A Winnicka; L Willems; R Kettmann; G H Cantor
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein.

Authors:  P Kerkhofs; H Heremans; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  Defibrinated bovine plasma inhibits retroviral transcription by blocking p52 activation of the NFkappaB element in the long terminal repeat.

Authors:  Marianne J van den Heuvel; Karen F Copeland; Elizabeth C Cates; Barbara J Jefferson; Robert M Jacobs
Journal:  Can J Vet Res       Date:  2007-04       Impact factor: 1.310

8.  In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.

Authors:  A Van Den Broeke; C Bagnis; M Ciesiolka; Y Cleuter; H Gelderblom; P Kerkhofs; P Griebel; P Mannoni; A Burny
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads.

Authors:  L Willems; J S Gatot; M Mammerickx; D Portetelle; A Burny; P Kerkhofs; R Kettmann
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  In vivo infection of sheep by bovine leukemia virus mutants.

Authors:  L Willems; R Kettmann; F Dequiedt; D Portetelle; V Vonèche; I Cornil; P Kerkhofs; A Burny; M Mammerickx
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.